A UK study has used dispensing data to understand how medicine use in England changed during and after the COVID-19 pandemic, ...

Poolbeg Pharma is preparing to start a clinical trial of a drug that aims to block a life-threatening side effect of cancer ...

A Reuters report suggests that pushback from the pharma companies – some of which have been threatening to reduce capital ...

Eisai has been given a grant from the UK government that will be used to expand a facility in Hatfield, Hertfordshire, which ...

Can the state of someone’s gut microbiome – the balance of good and bad bacteria in their digestive tract – affect their ...

Community pharmacy is not a pressure valve for an overburdened NHS. It is a clinical asset with the potential to reshape how ...

The FDA has started a review of Gilead Sciences' once-weekly oral medicine for HIV pre-exposure prophylaxis (PrEP), and is due to deliver its verdict by 2nd February next year. If approved, the oral ...

The results of the BRUIN CLL-322 trial, reported at the EHA congress, showed that adding the non-covalent BTK inhibitor to ...

A new study will attempt to improve screening for one of the fastest-growing drug-resistant bacterial threats facing ...

Across the US, the UK, and parts of Europe, CGT progress is being held back by an inability to secure starting material ...

The late-stage MonumenTAL-3 trial of Talvey (talquetamab), given in combination with J&J and Genmab's anti-CD38 antibody ...